BioSpace News Archive

The Leukemia & Lymphoma Society (LLS) continues to deliver on its promise to “Beat AML,” the deadliest of the blood cancers, through its groundbreaking Beat AML® Master Clinical Trial, a precision medicine approach to treating these cancer patients.

Donors wanting to help sick children travel for needed medical care will be able to double the impact of their contribution next week through the Aeroplan Miles Matching campaign in support of the Air Canada Foundation Hospital Transportation Program.

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”) today announced the closing of its previously announced underwritten public offering of 4,082,500 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 532,500 additional shares of its common stock, at a public offering price of $15.50 per share.

Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):

Crown Laboratories, Inc. (“Crown Laboratories”), a leading, fully integrated skin care company and Hildred Capital Partners LLC (“Hildred”) portfolio company, today announced it has acquired North American distribution rights of five (5) OTC consumer brands from GlaxoSmithKline (“GSK”).

Puration, Inc. (USOTC: PURA) today announced being featured in a Goldman Small Cap Research update on Generex Biotechnology Corp. (USOTC: GNBT)

CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX: TRST), one of Canada’s leading and most trusted licensed producers of cannabis, is thrilled to announce that it has won seven top 2018 Canadian Cannabis Awards, dominating the annual industry awards

Jupiter Medical Center is the first hospital in the southeastern United States to use SpineJack®, an implantable system that relieves the pain of acute vertebral compression fractures (VCFs), the most common fracture in patients with osteoporosis

Co-Diagnostics, Inc. announced today that it will discuss the Company’s recent progress and upcoming sales expectations on Tuesday, December 4, 2018 at 4:00 pm ET (3:00 pm CT) in a Lytham Partners’ Virtual Investors Conference Presentation.

Apple contributes a milestone $200 million to date in the fight against AIDS